Cluster of Differentiation 74 (Cd74) |
Cd74 is overexpressed in breast cancer patients. It is also found to be significantly correlated with lymph node metastasis in TNBC [38] |
Epigenetic mechanisms play a role in Cd74 expression via Cd74 promoter methylation [39] |
DEG, significant decrease (4.76 fold) |
Lipoprotein lipase (Lpl) |
Breast cancer and sarcoma cells express and secrete active Lpl enzyme to acquire fatty acids from the blood circulation, which facilitate growth of these cells [40] |
Epigenetic changes at the promoter regions may alter expression of the Lpl gene and may play an important role in prostate cancer development [41] |
DEG, significant decrease (2.8 fold) |
Frizzled 9 (Fzd9) |
Oncogene. Overexpressed Fzd9 is found in various types of cancer [42,43] |
Hypermethylated Fzd9 is associated with hormone receptor positive, luminal A, or p53 wild-type breast cancers [44] |
DEG, significant decrease (1.18 fold) |
Spermidine/spermine-N1-acetyltransferase 1 (Sat1) |
Sat1 overexpression is correlated with poor clinical outcomes [45] |
Sat1 is involved in acetylation of histone H3, resulting in chromatin remodeling and regulation of gene expression [45] |
DEG, significant decrease (0.82 fold) |
Interferon-Induced Protein 44 (Ifi44) |
Oncogene. Overexpressed Ifi44 is found in head and neck squamous cell carcinoma and functioned heterogeneously in tumor formation and progression [46] |
Iifi44 promoter hypomethylation can distinguish systemic lupus erythematosus patients from healthy persons, promising to be first novel epigenetic diagnostic marker [47] |
DEG, significant decrease (2.19 fold) |
WW and C2 domain containing 1 (Wwc1) |
Tumor-suppressor gene. Low Wwc1 expression is associated with aggressive breast cancer and poor survival outcomes [48] |
DNA methylation is negatively correlated with Wwc1 expression [48] |
DEG, significant increase (0.90 fold) |